{"id":"SEC-10-006","kind":"order","level":"federal","jurisdiction":"United States","state":"","metro":"","industry":"10","agency":"","eco":"","issuer":"President (Executive Order 13944)","authority":"DPA; Buy American Act; procurement statutes","instrument":"Executive Order 13944, Combating Public Health Emergencies and Strengthening National Security by Ensuring Essential Medicines, Medical Countermeasures, and Critical Inputs Are Made in the United States","title":"85 Fed. Reg. 49929 (Aug. 14, 2020)","dateIssued":"2020-08-06","effective":"2020-08-06","end":"Continuing (revised by EO 14001 and EO 14017 policy)","startDate":"2020-08-06","endDate":"2021-09-30","quarters":["2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","OTHER"],"addressees":["federal agencies","FDA","manufacturers of essential medicines, countermeasures and critical inputs"],"clause":"agencies shall... limit competition to only Essential Medicines, Medical Countermeasures, and Critical Inputs that are produced in the United States","enforcement":"Procurement regulations; FAR","functions":["DS (federal procurement redirected to domestic producers)","SC (foreign inputs displaced)"],"notes":"Context for pharmaceutical, chemical and device manufacturers and their foreign suppliers; procurement directive, pleaded as an order limiting commerce in federal purchases","sourceUrl":"https://www.govinfo.gov/content/pkg/FR-2020-08-14/pdf/2020-18012.pdf","snapshot":"","fileExists":true,"fileBytes":189985,"grade":"primary","character":"","description":"","collection":"SEC-10","url":"/library/SEC-10-006","exhibitUrl":"/exhibit/SEC-10-006","citation":"President (Executive Order 13944), Executive Order 13944, Combating Public Health Emergencies and Strengthening National Security by Ensuring Essential Medicines, Medical Countermeasures, and Critical Inputs Are Made in the United States (Aug. 6, 2020) (Ex. SEC-10-006)","stateName":"","related":[]}